
ThermoGenesis Holdings, Inc. – NASDAQ:THMO
ThermoGenesis Holdings stock price today
ThermoGenesis Holdings stock price monthly change
ThermoGenesis Holdings stock price quarterly change
ThermoGenesis Holdings stock price yearly change
ThermoGenesis Holdings key metrics
Market Cap | 2.37M |
Enterprise value | 716.28K |
P/E | -0.11 |
EV/Sales | 0.06 |
EV/EBITDA | -0.14 |
Price/Sales | 0.12 |
Price/Book | 0.29 |
PEG ratio | -0.11 |
EPS | -4.75 |
Revenue | 9.61M |
EBITDA | -4.82M |
Income | -14.74M |
Revenue Q/Q | 6.41% |
Revenue Y/Y | -7.52% |
Profit margin | -107.51% |
Oper. margin | -59.08% |
Gross margin | 25.85% |
EBIT margin | -59.08% |
EBITDA margin | -50.24% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeThermoGenesis Holdings stock price history
ThermoGenesis Holdings stock forecast
ThermoGenesis Holdings financial statements
Jun 2023 | 2.27M | -2.26M | -99.43% |
---|---|---|---|
Sep 2023 | 2.19M | -3.61M | -164.77% |
Dec 2023 | 2.40M | -7.01M | -291.52% |
Mar 2024 | 2.73M | -1.85M | -67.81% |
2027 | 25.11M | 828.83K | 3.3% |
---|
Analysts Price target
Financials & Ratios estimates
2024-03-28 | -0.01 | -1.9387 |
---|---|---|
2024-04-15 | -0.01585 | -2.33 |
Jun 2023 | 17608000 | 14.98M | 85.08% |
---|---|---|---|
Sep 2023 | 15921000 | 12.65M | 79.51% |
Dec 2023 | 11232000 | 14.81M | 131.91% |
Mar 2024 | 10087000 | 11.17M | 110.78% |
Jun 2023 | -812K | -590K | 0 |
---|---|---|---|
Sep 2023 | -251K | -180K | 0 |
Dec 2023 | -2.04M | -192K | 217K |
Mar 2024 | -505K | -20K | -299K |
ThermoGenesis Holdings alternative data
Aug 2023 | 40 |
---|---|
Sep 2023 | 40 |
Oct 2023 | 40 |
Nov 2023 | 40 |
Dec 2023 | 40 |
Jan 2024 | 40 |
Feb 2024 | 40 |
Mar 2024 | 40 |
Apr 2024 | 40 |
May 2024 | 25 |
Jun 2024 | 25 |
Jul 2024 | 25 |
ThermoGenesis Holdings other data
Period | Buy | Sel |
---|---|---|
Nov 2023 | 0 | 600000 |
Quarter | Transcript |
---|---|
Q3 2023 13 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 11 Aug 2023 | Q2 2023 Earnings Call Transcript |
Q1 2023 15 May 2023 | Q1 2023 Earnings Call Transcript |
Q4 2022 31 Mar 2023 | Q4 2022 Earnings Call Transcript |
Insider | Compensation |
---|---|
Dr. Xiaochun Xu M.B.A., Ph.D. (1971) Chairman & Chief Executive Officer | $781,000 |
Mr. Jeffery Cauble CPA (1973) Chief Financial Officer, Principal Financial & Accounting Officer and Corporation Sec. | $244,000 |
-
What's the price of ThermoGenesis Holdings stock today?
One share of ThermoGenesis Holdings stock can currently be purchased for approximately $0.
-
When is ThermoGenesis Holdings's next earnings date?
Unfortunately, ThermoGenesis Holdings's (THMO) next earnings date is currently unknown.
-
Does ThermoGenesis Holdings pay dividends?
No, ThermoGenesis Holdings does not pay dividends.
-
How much money does ThermoGenesis Holdings make?
ThermoGenesis Holdings has a market capitalization of 2.37M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 9.9% to 9.45M US dollars. ThermoGenesis Holdings made a loss 17.98M US dollars in net income (profit) last year or -$2.33 on an earnings per share basis.
-
What is ThermoGenesis Holdings's stock symbol?
ThermoGenesis Holdings, Inc. is traded on the NASDAQ under the ticker symbol "THMO".
-
What is ThermoGenesis Holdings's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of ThermoGenesis Holdings?
Shares of ThermoGenesis Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are ThermoGenesis Holdings's key executives?
ThermoGenesis Holdings's management team includes the following people:
- Dr. Xiaochun Xu M.B.A., Ph.D. Chairman & Chief Executive Officer(age: 54, pay: $781,000)
- Mr. Jeffery Cauble CPA Chief Financial Officer, Principal Financial & Accounting Officer and Corporation Sec.(age: 52, pay: $244,000)
-
How many employees does ThermoGenesis Holdings have?
As Jul 2024, ThermoGenesis Holdings employs 25 workers, which is 38% less then previous quarter.
-
When ThermoGenesis Holdings went public?
ThermoGenesis Holdings, Inc. is publicly traded company for more then 38 years since IPO on 5 Jun 1987.
-
What is ThermoGenesis Holdings's official website?
The official website for ThermoGenesis Holdings is thermogenesis.com.
-
Where are ThermoGenesis Holdings's headquarters?
ThermoGenesis Holdings is headquartered at 2711 Citrus Road, Rancho Cordova, CA.
-
How can i contact ThermoGenesis Holdings?
ThermoGenesis Holdings's mailing address is 2711 Citrus Road, Rancho Cordova, CA and company can be reached via phone at +91 68585100.
ThermoGenesis Holdings company profile:

ThermoGenesis Holdings, Inc.
thermogenesis.comNASDAQ
25
Medical - Devices
Healthcare
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company manufactures and markets AXP II Automated Cell Separation System, an automated cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. It offers PXP Point-of-Care System, an automated sterile system for the automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; PXP-LAVARE System, an automated system designed to wash, re-suspend, and volume reduce cell suspensions; PXP-1000 System, an automated system for fast and reproducible separation of multiple cellular components from blood with minimal red blood cell contamination; and X-Series products, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, X-Mini for small scale cell purification, and X-BACS System under development for large scale cell purification. It also provides CAR-TXpress Platform that addresses the critical unmet need for large scale cellular processing and chemistry, manufacturing, and controls needs. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.
Rancho Cordova, CA 95742
CIK: 0000811212
ISIN: US88362L2097
CUSIP: 88362L100